Alterations in enzymatic functions in hepatocytes and hepatocellular carcinomas from Ras-transduced livers resemble the effects of insulin

Hepatology

Volumn 24, Issue 4 I, 1996, Pages 838-848

  Pearline, Rachel V ^a,b   Lin, Yue Zhen ^a,b   Shen, Katherine J ^a,b   Brunt, Elizabeth M ^c   Bowling, William M ^b   Hafenrichter, Daniel G ^b   Kennedy, Susan ^a,b   Flye, M Wayne ^b   Ponder, Katherine Parker ^a,b,d  

^a School of Medicine   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DIETHYLNITROSAMINE; INSULIN; PROTEIN P21;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENETIC TRANSDUCTION; HISTOCHEMISTRY; HUMAN; LIPOGENESIS; LIVER CELL CARCINOMA; LIVER CELL CULTURE; LIVER METABOLISM; MALE; MOUSE; ONCOGENE RAS; PRIORITY JOURNAL;

EID: 0029811059     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008855186     Document Type: Article

References (85)

1. Anderson MW, Reynolds SH, You M, Maronpot RM. Role of proto-oncogene activation in carcinogenesis. Environ Health Perspect 1992;98:13-24.
2. Lea MA. Regulation of gene expression in hepatomas. Int J Biochem 1993; 25:457-469.
3. Unsal H, Yakicier C, Marcais C, Kew M, Volkmann M, Zentgraf H, Isselbacher KJ, et al. Genetic heterogeneity of hepatocellular carcinoma. Proc Natl Acad Sci U S A 1994;91:822-826.
4. Wands IR, Blum HE. Primary hepatocellular carcinoma. N Engl J Med 1991;325:729-731.
5. Harris H. The role of differentiation in the suppression of malignancy. J Cell Sci 1990;97:5-10.
6. Auersperg N, Roskelley C. Retroviral oncogenes: interrelationships between neoplastic transformation and cell differentiation. Crit Rev Oncog 1991;2:125-136.
7. Uriel J. Cancer, retrodifferentiation, and the myth of Faust. Cancer Res 1976;36:4269-4275.
8. Umek RM, Friedman AD, McKnight SL. CCAAT/enhancer binding protein: a component of a differentiation switch. Science 1991;251:288-292.
9. Love JM, Gudas LJ. Vitamin A, differentiation and cancer. Curr Opin Cell Biol 1994;6:825-831.
10. Coleman WB, Wennerberg AE, Smith GJ, Grisham JW. Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment. Am J Pathol 1993;142:1373-1382.
11. Board M, Colquhoun A, Newsholme EA. High Km glucose-phosphorylating activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose. Cancer Res 1995; 55:3278-3285.
12. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 1995;80:199-211.
13. Medema RH, Bos JL. The role of p21-ras in receptor tyrosine kinase signaling. Crit Rev Oncog 1993;4:615-661.
14. Lee G-H, Li H, Ohtake K, Nomura K, Hino O, Furata Y, Aizawa S, et al. Detection of activated c-H-ras oncogene in hepatocellular carcinomas developing in transgenic mice harboring albumin promoter-regulated SV40 gene. Carcinogenesis 1990;11:1145-1148.
15. Beer D, Schwarz M, Sawada N, Pitot HC. Expression of H-ras and c-myc proto-oncogenes in isolated GGT-positive rat hepatocytes and in hepatocellular carcinomas induced by DEN. Cancer Res 1986;46:2435-2441.
16. Buchmann A, Bauer-Hoffman R, Mahr J, Drinkwater NR, Luz A, Schwartz M. Mutational activation of the c-Ha-ras gene in liver tumors of differents rodent strains: correlation with susceptibility to hepatocarcinogenesis. Proc Natl Acad Sci U S A 1991;88:911-915.
17. Chandar N, Lombardi B, Schulz W, Locker J. Analysis of ras genes and linked viral sequences in rat hepatocarcinogenesis. Am J Pathol 1987;129: 232-241.
18. Tokusashi Y, Fukada I, Ogawa K. Absence of p53 mutations and various frequencies of Ki-ras exon 1 mutations in rat hepatic tumors induced by different carcinogens. Mol Carcinog 1994;10:45-51.
19. Yaswen P, Goyette M, Shank PR, Fausto N. Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis. Mol Cell Biol 1985;5:780-786.
20. Chen B, Liu L, Castonguay A, Maronpot RR, Anderson MW, You M. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis 1993;14:1603-1608.
21. Tada M, Omata M, Ohto M. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Cancer Res 1990;50:1121-1124.
22. Tsuda H, Hirohashi S, Shimosato Y, Ino Y, Yoshida T, Terasa M. Low incidence of point mutations of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res 1989;80:196-199.
23. Ogato N, Kamimura T, Asakura H. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma. HEPATOLOGY 1991;13:31-37.
24. Gu J-R, Hu L-F, Cheng Y-C, Wan D-F. Oncogenes in human primary hepatic cancer. J Cell Physiol 1986;4(suppl):13-20.
25. Richards CA, Short SA, Thorgeirrson SS, Huber BE. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis. Cancer 1990;50:1521-1527.
26. Lin Y-Z, Brunt E, Bowling W, Hafenrichter DG, Kennedy S, Flye MW, Ponder KP. Ras-transduced diethylnitrosamine-treated hepatocytes develop into cancers of mixed phenotype in vivo. Cancer Res 1995;55:5242-5250.
27. Rettinger S, Kennedy S, Wu X, Flye MW, Ponder KP. Liver-directed gene therapy: quantitative evaluation of promoter elements using in vivo retroviral transduction. Proc Natl Acad Sci U S A. 1994;91:1460-1464.
28. Ghattas IR, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosome entry site allows efficient co-expression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol 1991; 11:5848-5857.
29. Yan C, Costa R, Darnell J, Chen J, Van Dyke T. Positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J 1990;9:869-878.
30. McCoy MS, Bargmann CI, Weinberg RA. Human colon carcinoma Ki-ras-2 oncogene and its corresponding proto-oncogene. Mol Cell Biol 1984;4: 1577-1582.
31. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src protooncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.
32. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988;167:400-406.
33. Jainchill JL, Aaronson SA, Todaro GJ. Murine sarcoma and leukemia viruses: assay using clonal lines of contact inhibited mouse cells. J Virol 1969;4:549-553.
34. Rettinger S, Ponder KP, Saylors R, Kennedy S, Hafenrichter D, Flye MW. In vivo transduction with retrovirus during in-flow occlusion. J Surg Res 1993;54:418-425.
35. Sheehan DC, Hrapchak BB. Theory and practice of histotechnology. St. Louis: Mosby, 1980:144;164-166;205.
36. Sasse D. Histology and histochemistry. In: Thurman RG, Kauffman FC, Jungermann K, eds. Regulation of hepatic metabolism. New York: Plenum, 1986:78-83.
37. Thomas E, Pearse AGE. The fine localization of dehydrogenases in the nervous system. Histochemie 1961;2:266-282.
38. Jacobsen NO, Jørgensen F. Further enzyme histochemical observations on the segmentation of the proximal tubules in the kidney of the male rat. Histochemie 1973;34:11-32.
39. Lojda Z, Gossrau R, Scheibler TH. Enzyme histochemistry: a laboratory manual. Berlin: Spronger-Verlag, 1979:223-269.
40. Chayen J, Bitensky L, Butcher RG, eds. Practical histochemistry. London: Wiley, 1973:111-196.
41. Rieder H, Teutsch HF, Sasse D. NADP-dependent dehydrogenases in rat liver parenchyma. Histochem Cell Biol 1978;56:283-298.
42. Stevens A. Enzyme histochemistry: diagnostic applications. In: Bancroft JD, Stevens A, eds. Theory and practice of histological techniques. Edinburgh: Churchill Livingstone, 1990:1:401-411.
43. Gomori G. Microscopic histochemistry: principles and practice. Chicago: University of Chicago Press, 1952.
44. Chiquoine AD. Distribution of G6Pase in the liver of the mouse. J Histochem Cytochem 1953;1:429-435.
45. Wachstein M, Meisel E. Histochemistry of hepatic phosphatases at a physiologic pH. Am J Clin Pathol 1957;13-23.
46. Mizutani A. Cytochemical demonstration of ornithine carbamoyltransferase activity in liver mitochondria of rat and mouse. J Histochem Cytochem 1968;16:172-180.
47. Mayer D, Hacker HJ, Bannasch P. Re-evaluation of the specificity of adenylyl (β,γ-methylene)diphosphonate as a substrate for adenylate cyclase. Histochem J 1991;23:100-106.
48. Rutenburg AM, Kim H, Fischbein JW, Hanker JS, Wasserkrug HL, Seligman AM. Histochemical and ultrastructural demonstration of γ-glutamyl transpeptidase activity. J Histochem Cytochem 1969;17:517-526.
49. Lawrence GM, Trayer IP, Walker DG. Histochemical and immunohistochemical localization of hexokinase isoenzymes in normal rat liver. Histochem J 1984;16:1099-1111.
50. Henderson B. Quantitative cytochemical measurement of glyceraldehyde 3-phosphate dehydrogenase activity. Histochem Cell Biol 1976;48:191-204.
51. Klimek F, Moore MA, Schneider E, Bannasch P. Histochemical and microbiochemical demonstration of reduced pyruvate kinase activity in thioacetamide-induced neoplastic nodules of rat liver. Histochem Cell Biol 1988;90:37-42.
52. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989;7:980-987.
53. MacGregor GR, Nolan GP, Fiering S, Roederer M, Herzenberg LA. Use of E. coli lac Z (β-galactosidase) as a reporter gene. In: Murray EJ, Walker JM, eds. Methods in molecular biology. Vol 7. Totowa: Humana Press Inc, 1993:317-327.
54. Ponder KP, Gupta S, Leland F, Darlington G, Finegold M, DeMayo J, Ledley F, et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A 1991;88:1217-1221.
55. Ohe K, Morris HP, Weinhouse S. β-Hydroxybutyrate dehydrogenase activity in liver and liver tumors. Cancer Res 1967;27:1360-1371.
56. Lee G-H, Merlino G, Fausto N. Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res 1992;52:5162-5170.
57. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL. Oncogene-induced liver neoplasia in transgenic mice. Oncogene 1989;4:715-724.
58. Okuda K, Kojiro M, Okuda H. Neoplasms of the liver. In: Schiff L, Schiff ER, eds. Diseases of the liver. 7th ed. Philadelphia: Lippincott, 1993:1236-1265.
59. Ruch RJ, Madhukar BV, Trosko JE, Klaunig JE. Reversal of ras-induced inhibition of gap-junctional intercellular communication, transformation, and tumorigeneses by lovastatin. Mol Carcinog 1993;7:50-59.
60. Kohl NE, Wilson FR, Mosser SD, Giuliani E, DeSolms SJ, Conner MW, Anthony NJ. Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. Proc Natl Acad Sci U S A 1994;91: 9141-9145.
61. Tamanoi F. Inhibitors of Ras farnesyltransferases. Trends Biochem Sci 1993;18:349-353.
62. Alpers DH, Sabesin SM, White HM. Fatty liver: biochemical and clinical aspects. In: Schiff L, Schiff ER, eds. Diseases of the liver. 7th ed. Philadelphia: Lippincott, 1993;2:825-855.
63. Lee J, Pilch PF. The insulin receptor; structure, function, and signaling. Am J Physiol 1994;266:C319-C334.
64. Vaulont S, Kahn A. Transcriptional control of metabolic regulation genes by carbohydrates. FASEB J 1994;8:28-35.
65. Lin TA, Lawrence JC. Activation of ribosomal protein S6 kinase does not increase glycogen synthetase or glucose transport in rat adipocytes. J Biol Chem 1994;269:21255-21261.
66. Sakaue H, Hara K, Noguchi T, Matozaki T, Kotani K, Ogawa W, Yonezawa K, et al. Ras-in dependent and wortmannin sensitive activation of glycogen synthetase by insulin in Chinese hamster ovary cells. J Biol Chem 1995; 270:11304-11309.
67. Pitot HC. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu Rev Toxicol 1990;30:465-500.
68. Bannasch P, Mayer D, Hacker H-J. Hepatocellular glycogenesis and hepatocarcinogenesis. Biochem Biophys Acta 1980;605:217-245.
69. Williams GM. The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochem Biophys Acta 1980;605:167-189.
70. Buchmann A, Kuhlmann W, Schwartz M, Kunz W, Wolf CR, Moll E, Friedberg T, et al. Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis 1985;6:513-521.
71. Hu J, Isom HC. Suppression of albumin enhancer activity by H-ras and AP1 in hepatocyte cell lines. Mol Cell Biol 1994;14:1531-1543.
72. Sirica AE, Mathis GA, Sano N, Elmore LW. Isolation, culture, and transplantation of intrahepatic biliary epithelial cells and oval cells. Pathobiology 1990;58:44-64.
73. Seifter S, Englard S. Energy metabolism. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, Shafritz DA, eds. The liver: biology and pathobiology. New York: Raven, 1994;323-364.
74. Denton RM, Tavare JM. Mechanisms whereby insulin may regulate intracellular events. In: Ashcroft FM, Ashcroft SJH, eds. Insulin: molecular biology to pathology. New York: IRL Press, 1992:235-256.
75. Pitot HC. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol 1990;30:465-500.
76. Mayer D, Klimek F, Hacker HJ, Bannasch P. Carbohydrate metabolism in hepatic pre-neoplasia. In: Bannasch P, Keppler D, Weber G, eds. Liver cell carcinoma. Boston: Kluwer Academic Publishers, 1988:329-346.
77. Toshkov I, Chisari FV, Bannasch P. Hepatic preneoplasia in hepatitis B virus transgenic mice. HEPATOLOGY 1994;20:1162-1172.
78. Weber G. Enzymology of cancer cells. N Engl J Med 1977;296:541-551.
79. O'Brian RM, Granner DK. Regulation of gene expression by insulin. Biochem J 1991;278:609-619.
80. Klimek F, Bannasch P. Isoenzyme shift from glucokinase to hexokinase is not an early but a late event in hepatocarcinogenesis. Carcinogenesis 1993;14:1857-1861.
81. Rieder H. NADP-dependent dehydrogenases in rat liver parenchyma. Histochem Cell Biol 1981;72:579-615.
82. Nepokroeff CM, Lakshmanan MR, Ness GC, Muesing RA, Kleinsek DA, Porter JW. Coordinate control of rat liver lipogenic enzymes by insulin. Arch Biochem Biophys 1974;162:340-344.
83. Kitagawa T. Histochemical analysis of hyperplastic lesions and hepatomas of the liver of rats red 2-fluorenylacetamide. Jpn J Cancer Res 1971;62: 207-216.
84. Weber G. Biochemical strategy of hepatocellular carcinoma. In: Bannasch P, Keppler D, Weber G, eds. Liver cell carcinoma. Boston: Kluwer Academic Publishers, 1988:361-374.
85. Sapag-Hagar M, Lagunas R, Sols A. Apparent unbalance between the activities of 6-phosphogluconate and glucose-6-phosphate dehydrogenases in rat liver. Biochem Biophys Res Commun 1973;50:179-185.